January 2026 Adult Collaborative Call

January 2026 Adult Collaborative Call 

January 27, 3:30-5pm EST 

January 2026 Adult Call FINAL SLIDES 

Coordinating Center Updates 

Presenter: Nicole Rioles, MA 

• Abstract submissions: 

• • T1DX submitted 14 abstracts to ADA. 

• • An additional 5 late-breaking abstracts will be submitted. 

• 2026 Annual Survey Questions: 

• • Proposals due May 1. 

• • Send to qi@t1dexchange.org and cc Nicole Rioles (nrioles@t1dexchange.org) and Claire Rainey (crainey@t1dexchange.org). 

• Learning Session abstracts will be published next month in the Journal of Diabetes. 

• • Learning Session presentations and posters are available on the member website (https://t1dx-qi.t1dexchange.org/2025-learning-session/). 

• New measures for 2026–2028 are live; additional details are available on the member website (https://t1dx-qi.t1dexchange.org/measures/). 

Screening and Monitoring Update 

• Overview of the Beta Cell Preservation Work Group. 

• The white paper has been developed and will be available for dissemination by February 23 on the T1D Exchange website. 

• Discussion question: Are adult centers considering workflow changes to incorporate increased Tzield use? 

 

Center Presentation: OHSU 

Presenters: Farahnaz Joarder, MD; Ryan Tweet, PsyD 

Topic: Screening Diabetes Distress: Evolution of the OHSU Experience 

• Overview of diabetes distress and its impact on health outcomes. 

• Introduction of the Type 1 Diabetes Distress Assessment System (T1-DDAS). 

• Project timeline: March 2022 – December 2025. 

• Dr. Joarder reviewed: 

• • Distribution of the correct questionnaire and completion processes. 

• • OHSU’s clinical workflow. 

• • Use of fishbone diagrams to identify barriers. 

• Dr. Tweet presented questionnaire completion trends at OHSU. 

• Provider experience: 

• • Concerns related to time constraints and addressing behavioral health needs. 

• • Diabetes distress provider workshops reviewed (past and upcoming). 

• Current focus (2025–2026): 

• • Evaluating how screening data is used in real clinical visits. 

• • Refining who receives the questionnaire and how often. 

• • Ongoing workflow review to reduce burden on patients and providers. 

• Distribution detail: Patients receive the T1-DDAS via MyChart 7 days prior to their appointment. 
• Please contact: joarder@ohsu.edu or tweet@ohsu.edu for questions or feedback. 

  

Center Presentation: University Hospitals Cleveland Medical Center 

Presenter: Clare Kelly, MD 

Topic: Screening for and Detecting Depression in Diabetes 

• ADA 2026 Standards of Care: Recommend screening for depressive symptoms in all people with diabetes. 

• Rationale: 

• • Approximately 1 in 4 people with diabetes are affected by depression. 

• • Depressive symptoms are associated with poorer health outcomes. 

• • Negative correlation exists between depression and self-care behaviors. 

• Prior to this project, depression screening was conducted as needed with no established interval. 

• Project Aim: 

• • Within six months, implement a routine depression screening protocol. 

• • Screen 90% of adult patients with type 1 diabetes during visits. 

• Fishbone diagrams identified barriers to depression screening. 

• Outcome: Screening rates reached approximately 80%, short of the 90% goal. 

• Impact of a positive PHQ-9: For scores ≥7, multiple follow-up pathways were initiated. 

• Key learnings discussed: 

• • What worked well. 

• • What required adjustment. 

• • Practical insights for replication. 

• Rationale for visit-based screening was reviewed. 

• Future directions: 

• • Expansion to additional clinical sites. 

• • Increased collaboration with mental health clinical partners. 

Q&A 

• Julia Blanchette, RN, PhD shared information regarding Blue Circle Health 

• UH requested tips related to Epic implementation; they have been live for less than two years. 

• Participants encouraged to reach out to UH with guidance or shared experience. 

Next Meeting: Tuesday, July 21st 3:30-5pm EST

Zoom Recording password: !j@oPY+4